Showing results 46 to 65 of 71
< previous
next >
| Issue Date | Title | Author(s) |
| 2022-03-02 | Pharmacist's time spent: Space for Pharmacy-based Interventions and Consultation TimE (SPICE)-an observational time and motion study. | Karia, A; Norman, R; Robinson, S; Lehnbom, E; Laba, T-L; Durakovic, I; Balane, C; Joshi, R; Webster, R |
| 2013-06-01 | A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states | Norman, R; Cronin, P; Viney, R |
| 2020-05 | PNS202 COMPARING PROMIS-29 AND EQ-5D-5L: SYNTHESISING EVIDENCE FROM LITERATURE AND COMPARING THE VALUE SETS | Pan, T; Mulhern, B; Viney, R; Duy Tran, A; Norman, R; Devlin, N |
| 2020-12 | PNS234 How Do the Utilities for Promis-29 and EQ-5D-5L Compare? a Comparison of Propr and EQ-5D-5L VALUE SETS, and Implications for Users | Pan, T; Mulhern, B; Viney, R; Norman, R; Hanmer, J; Devlin, N |
| 2022-07 | Preference Elicitation Techniques Used in Valuing Children's Health-Related Quality-of-Life: A Systematic Review. | Bailey, C; Howell, M; Raghunandan, R; Salisbury, A; Chen, G; Coast, J; Craig, JC; Devlin, NJ; Huynh, E; Lancsar, E; Mulhern, BJ; Norman, R; Petrou, S; Ratcliffe, J; Street, DJ; Howard, K; Viney, R; Quality of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA), Tools for Outcomes Research to Measure, Value Child Health (TORCH) Project Teams, |
| 2012-05-01 | Preferences for cancer treatments: An overview of methods and applications in oncology | Blinman, P; King, M; Norman, R; Viney, R; Stockler, MR |
| 2014-01-01 | A protocol for a discrete choice experiment: understanding preferences of patients with cancer towards their cancer care across metropolitan and rural regions in Australia | Wong, SF; Norman, R; Dunning, TL; Ashley, DM; Lorgelly, PK |
| 2021-03-04 | Public Preferences for Allocating Ventilators in an Intensive Care Unit: A Discrete Choice Experiment | Norman, R; Robinson, S; Dickinson, H; Williams, I; Meshcheriakova, E; Manipis, K; Anstey, M |
| 2016-02-01 | Response Patterns in Health State Valuation Using Endogenous Attribute Attendance and Latent Class Analysis | Hole, AR; Norman, R; Viney, R |
| 2023-01-16 | Self-Perception of Cognitive-Communication Functions After Mild Traumatic Brain Injury. | Norman, R; Flaugher, T; Chang, S; Power, E |
| 2023-11-09 | Systematic Review of the Relative Social Value of Child and Adult Health. | Peasgood, T; Howell, M; Raghunandan, R; Salisbury, A; Sellars, M; Chen, G; Coast, J; Craig, JC; Devlin, NJ; Howard, K; Lancsar, E; Petrou, S; Ratcliffe, J; Viney, R; Wong, G; Norman, R; Donaldson, C; Quality Of Life in Kids: Key evidence to strengthen decisions in Australia (QUOKKA), Tools for Outcomes Research to measure, value Child Health (TORCH) project teams, |
| 2018 | Test-retest reliability of discrete choice experiment for valuations of QLU-C10D health states | Gamper, E; Kemmler, G; Holzner, B; Norman, R; King, M; Viney, RC |
| 2022-06-16 | The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study. | McTaggart-Cowan, H; King, MT; Norman, R; Costa, DSJ; Pickard, AS; Viney, R; Peacock, SJ; Canadian MAUCa Team, |
| 2021-06-01 | The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set | King, MT; Norman, R; Mercieca-Bebber, R; Costa, DSJ; McTaggart-Cowan, H; Peacock, S; Janda, M; Muller, F; Viney, R; Pickard, AS; Cella, D |
| 2021-06 | The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set. | King, MT; Norman, R; Mercieca-Bebber, R; Costa, DSJ; McTaggart-Cowan, H; Peacock, S; Janda, M; Müller, F; Viney, R; Pickard, AS; Cella, D; Multi-Attribute Utility in Cancer Consortium, |
| 2023-04 | The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia. | Norman, R; Mulhern, B; Lancsar, E; Lorgelly, P; Ratcliffe, J; Street, D; Viney, R |
| 2011-01-01 | Time trade-off derived EQ-5D weights for Australia | Viney, R; Norman, R; King, MT; Cronin, P; Street, DJ; Knox, S; Ratcliffe, J |
| 2019 | U.K. utility weights for the EORTC QLU‐C10D | Norman, R; Mercieca-Bebber, R; Rowen, D; Brazier, JE; Cella, D; Pickard, AS; Street, DJ; Viney, R; King, MT |
| 2013-03-01 | Understanding the costs of care for cystic fibrosis: An analysis by age and health state | Van Gool, K; Norman, R; Delatycki, MB; Hall, J; Massie, J |
| 2023-11 | Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr. | Mulhern, BJ; Pan, T; Norman, R; Tran-Duy, A; Hanmer, J; Viney, R; Devlin, NJ |
